Harnessing pharmacovigilance to turn reactive investigation into active discovery
Pharmacovigilance uses science and action to detect, assess, understand and prevent adverse events (AEs) or other issues relating to medicines…
Pharmacovigilance uses science and action to detect, assess, understand and prevent adverse events (AEs) or other issues relating to medicines…
Highlighted by the introduction of regulatory stipulation in August 2023, real-time monitoring for cleanrooms involves using particle counters and other…
Generative artificial intelligence (AI) or gen AI refers to algorithms that can produce new content such as codes, text, images…
Tuberculosis or TB is the leading cause of death in people with HIV. Moreover, people living with HIV are at…
Counterfeit drug production and distribution has increased in recent years. Disruption from the Covid-19 pandemic, business resilience impacts, and rapid…
As patient organisations play a part in regulatory issues and contribute to health institutions’ guideline development, recent research finds many…
More than seven years since Brexit and almost four years since the arrival of Covid-19, the last year saw the…
Cold chain logistics have improved after the approval of new cell therapies and a significant learning curve around transporting Covid-19…
The Covid-19 pandemic heavily restricted the ability of sales reps to enter doctor’s offices and hospitals, changing the world of…
Using supercritical fluids to sterilise processes, equipment and bioreactors in pharmaceutical manufacturing is driving new insights and innovations. Supercritical fluids…